Correlation studies suggested that the expression of CEP55 in gallbladder cancer was significantly positively correlated with that of PLK1, indicating that CEP55 has potential as a molecular target for gallbladder cancer therapy like PLK1. This evidence concerns the gene PLK1 and gallbladder cancer.